These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Therapeutic effects of epoetin zeta in the treatment of chemotherapy-induced anaemia. Tzekova V, Mihaylov G, Elezovic I, Koytchev R, Epoetin Zeta Oncology Study Group. Curr Med Res Opin; 2009 Jul; 25(7):1689-97. PubMed ID: 19505200 [Abstract] [Full Text] [Related]
24. Pharmacokinetics and pharmacodynamics of intravenous epoetin alfa in children with cancer. Freeman BB, Hinds P, Iacono LC, Razzouk BI, Burghen E, Stewart CF. Pediatr Blood Cancer; 2006 Oct 15; 47(5):572-9. PubMed ID: 16317760 [Abstract] [Full Text] [Related]
29. Association of breast cancer stem cells identified by aldehyde dehydrogenase 1 expression with resistance to sequential Paclitaxel and epirubicin-based chemotherapy for breast cancers. Tanei T, Morimoto K, Shimazu K, Kim SJ, Tanji Y, Taguchi T, Tamaki Y, Noguchi S. Clin Cancer Res; 2009 Jun 15; 15(12):4234-41. PubMed ID: 19509181 [Abstract] [Full Text] [Related]
35. Management of cancer-related anemia in patients with breast or gynecologic cancer: new insights based on results from the European Cancer Anemia Survey. Barrett-Lee P, Bokemeyer C, Gascón P, Nortier JW, Schneider M, Schrijvers D, Van Belle S, ECAS Advisory Board and Participating Centers. Oncologist; 2005 Oct 15; 10(9):743-57. PubMed ID: 16249356 [Abstract] [Full Text] [Related]
38. Impact of Granulocyte Colony-Stimulating Factor (G-CSF) and Epoetin (EPO) on Hematologic Toxicities and Quality of Life in Patients During Adjuvant Chemotherapy in Early Breast Cancer: Results From the Multi-Center Randomized ADEBAR Trial. Bekes I, Eichler M, Singer S, Friedl TWP, Harbeck N, Rack B, Forstbauer H, Dannecker C, Huober J, Kiechle M, Lato K, Janni W, Fink V. Clin Breast Cancer; 2020 Dec 15; 20(6):439-447. PubMed ID: 32800493 [Abstract] [Full Text] [Related]